Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel.
Biomark Res. 2023 Jul 25;11(1):73. doi: 10.1186/s40364-023-00511-7.
Biomark Res. 2023.
PMID: 37491309
Free PMC article.
Targeting HER2/HER3 co-mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy.
Blas PE, Rodriguez ESR, Williams HL, Levin MK, Bell JSK, Pierobon M, Barrett AS, Petricoin EF, O'Shaughnessy JA.
Blas PE, et al.
Cancer Rep (Hoboken). 2024 Mar;7(3):e1954. doi: 10.1002/cnr2.1954.
Cancer Rep (Hoboken). 2024.
PMID: 38441358
Free PMC article.
Item in Clipboard
Cite
Cite